Needs, Experiences, and Views of People With Rheumatic and Musculoskeletal Diseases on Self-Management Mobile Health Apps: Mixed Methods Study

被引:36
|
作者
Najm, Aurelie [1 ,2 ]
Lempp, Heidi [3 ]
Gossec, Laure [4 ,5 ]
Berenbaum, Francis [6 ,7 ,8 ]
Nikiphorou, Elena [3 ]
机构
[1] Nantes Univ Hosp, Dept Rheumatol, 1 Pl Alexis Ricordeau, Nantes, France
[2] INSERM UMR 1238, Nantes, France
[3] Kings Coll London, Fac Life Sci & Med, Ctr Rheumat Dis, Sch Immunol & Microbial Sci,Dept Inflammat Biol, London, England
[4] Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, INSERM UMR S1136, Paris, France
[5] Hop La Pitie Salpetriere, AP HP, Rheumatol Dept, Paris, France
[6] St Antoine Hosp, AP HP, Dept Rheumatol, Paris, France
[7] Sorbonne Univ, Paris, France
[8] INSERM CRSA, Paris, France
来源
JMIR MHEALTH AND UHEALTH | 2020年 / 8卷 / 04期
关键词
mHealth; mixed methods; mobile health apps; rheumatic and musculoskeletal disease; smartphone; apps; rheumatoid arthritis; digital health; mobile health; MEDICAL APPS; SMARTPHONE; TECHNOLOGY; ARTHRITIS; DEVICES; DESIGN;
D O I
10.2196/14351
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Despite the growing interest and exponential popularity of mobile health (mHealth) apps for long-term conditions such as rheumatic and musculoskeletal diseases (RMDs) and their self-management, patients are rarely directly consulted and involved in the app development process. Objective: This study aims to explore the needs, experiences, and views of people diagnosed with RMDs on mHealth apps. Methods: The study used a mixed methods approach: (1) an initial qualitative phase via a patient focus group in the UK and (2) a survey disseminated through national organizations for patients with RMDs across European countries, the United States, Canada, and Australia. Results: The focus group included six patients with life-long musculoskeletal conditions. Half had used a self-management app at least once. The use of existing apps was reported as time-consuming due to a lack of functionality. The need for bespoke apps was voiced by all participants. Among 424 patients across European countries, the United States, Canada, and Australia, the main age group was 45 to 54 years (122/424, 28.7%), and 86.8% (368/424) were women. Half of the respondents were aware of the existence of apps to support self-management of their RMDs (188/355, 53%), with 42% (79/188) of them currently using such devices. Patients were mostly interested in an app to self-monitor their health parameters (259/346, 74.9%) and disease activity (221/346, 63.9%) or communicate directly with their health care provider (200/346, 57.8%). Conclusions: Patients considered that using an app could help them to self-manage their RMD condition if it was tailored to their needs and co-developed with health professionals. The development of such apps will require standardization and regular quality control.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Mobile Health Apps for Self-Management of Rheumatic and Musculoskeletal Diseases: Systematic Literature Review
    Najm, Aurelie
    Gossec, Laure
    Weill, Catherine
    Benoist, David
    Berenbaum, Francis
    Nikiphorou, Elena
    JMIR MHEALTH AND UHEALTH, 2019, 7 (11):
  • [2] EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases
    Najm, Aurelie
    Nikiphorou, Elena
    Kostine, Marie
    Richez, Christophe
    Pauling, John D.
    Finckh, Axel
    Ritschl, Valentin
    Prior, Yeliz
    Balazova, Petra
    Stones, Simon
    Szekanecz, Zoltan
    Iagnocco, Annamaria
    Ramiro, Sofia
    Sivera, Francisca
    Dougados, Maxime
    Carmona, Loreto
    Burmester, Gerd
    Wiek, Dieter
    Gossec, Laure
    Berenbaum, Francis
    RMD OPEN, 2019, 5 (02):
  • [3] Users' Experiences of a Mobile Health Self-Management Approach for the Treatment of Cystic Fibrosis: Mixed Methods Study
    Floch, Jacqueline
    Vilarinho, Thomas
    Zettl, Annabel
    Ibanez-Sanchez, Gema
    Calvo-Lerma, Joaquim
    Stav, Erlend
    Halland Haro, Peter
    Lein Aalberg, Asbjorn
    Fides-Valero, Alvaro
    Bayo Monton, Jose Luis
    JMIR MHEALTH AND UHEALTH, 2020, 8 (07):
  • [4] Assessing the Views and Needs of People at High Risk of Gestational Diabetes Mellitus for the Development of Mobile Health Apps: Descriptive Qualitative Study
    Duan, Beibei
    Liu, Zhe
    Liu, Weiwei
    Gou, Baohua
    JMIR FORMATIVE RESEARCH, 2022, 6 (07)
  • [5] Evaluation of Digital Technologies Tailored to Support Young People's Self-Management of Musculoskeletal Pain: Mixed Methods Study
    Slater, Helen
    Stinson, Jennifer N.
    Jordan, Joanne E.
    Chua, Jason
    Low, Ben
    Lalloo, Chitra
    Pham, Quynh
    Cafazzo, Joseph A.
    Briggs, Andrew M.
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2020, 22 (06)
  • [6] Supporting Management of Noncommunicable Diseases With Mobile Health (mHealth) Apps: Experimental Study
    Kela, Neta
    Eytam, Eleanor
    Katz, Adi
    JMIR HUMAN FACTORS, 2022, 9 (01):
  • [7] Apps for Older People's Pain Self-Management: Perspectives of Primary Care and Allied Health Clinicians
    Bhattarai, Priyanka
    Newton-John, Toby
    Phillips, Jane L.
    PAIN MEDICINE, 2020, 21 (04) : 686 - 694
  • [8] Information needs and perceptions of chatbots for hypertension medication self-management: a mixed methods study
    Griffin, Ashley C.
    Xing, Zhaopeng
    Mikles, Sean P.
    Bailey, Stacy
    Khairat, Saif
    Arguello, Jaime
    Wang, Yue
    Chung, Arlene E.
    JAMIA OPEN, 2021, 4 (02)
  • [9] The biopsychosocial perspective on designing mobile health apps for self-management of chronic headaches
    Durneva, Polina
    Lerouge, Cynthia
    HEALTH SYSTEMS, 2024,
  • [10] Automatic market research of mobile health apps for the self-management of allergic rhinitis
    Anto, Aram
    Sousa-Pinto, Bernardo
    Czarlewski, Wienczyslawa
    Pfaar, Oliver
    Bosnic-Anticevich, Sinthia
    Klimek, Ludger
    Matricardi, Paolo
    Tripodi, Salvatore
    Fonseca, Joao A.
    Anto, Josep M.
    Bousquet, Jean
    CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (10) : 1195 - 1207